Improving Local Control in Rectal Cancer: Radiation Sensitizers or Radiation Dose?

This publication has 7 references indexed in Scilit:

• Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
  Journal of Clinical Oncology, 2010
• Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial
  Journal of Clinical Oncology, 2009
• Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
  Journal of Clinical Oncology, 2009
• The concurrent chemoradiation paradigm—general principles
  Nature Clinical Practice Oncology, 2007
• Phase I/II Study of Preoperative Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy in Patients With Locally Advanced Rectal Cancer: Cancer and Leukemia Group B 89901
  Journal of Clinical Oncology, 2006
• Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
  Journal of Clinical Oncology, 2005
• 202 Oxaliplatin: In vitro evidence of its radiation sensitizing activity — preclinical observations relevant to clinical trials
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999